# Refobacin Revision-3 Bone Cement Post-Market Study

> **NCT06699160** · — · WITHDRAWN · sponsor: **Zimmer Biomet**

## Conditions studied

- Revision Arthroplasty

## Interventions

- **DEVICE:** Revision arthroplasty

## Key facts

- **NCT ID:** NCT06699160
- **Lead sponsor:** Zimmer Biomet
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-08
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was discontinued upon availability of relevant data through bespoke reporting, which fulfilled the study's primary objectives
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06699160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06699160, "Refobacin Revision-3 Bone Cement Post-Market Study". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06699160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*